Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome

Open access

Abstract

BACKGROUND: Accumulating evidence supports the view that an imbalance of gut bacteria contributes to IBS, and that increasing the mass of beneficial species may reduce the numbers of pathogenic bacteria and help alleviate symptoms. METHODS: In this double-blind trial 400 adult patients with moderate-to-severe symptomatic diarrhea-predominant IBS (IBS-D) were randomized to treatment with the multi-strain probiotic Bio-Kult® (14 different bacterial strains) or placebo for 16 weeks. The change in severity and frequency of abdominal pain was the primary outcome measure. RESULTS: Probiotic treatment significantly improved the severity of abdominal pain in patients with IBS-D. A 69% reduction for probiotic versus 47% for placebo (p < 0.001) equates to a 145 point reduction on the IBS-severity scoring system (IBS-SSS). The proportion of patients who rated their symptoms as moderate-to-severe was reduced from 100% at baseline to 14% for the multi-strain probiotic at follow-up (month 5) versus 48% for placebo (p < 0.001). Also, the number of bowel motions per day from month 2 onwards was significantly reduced in the probiotic group compared with the placebo group (p < 0.05). In addition to relieving symptoms, the probiotic markedly improved all dimensions of quality of life in the 34-item IBS-Quality of Life (IBS-QoL) questionnaire. No serious adverse events were reported. CONCLUSIONS: The multi-strain probiotic was associated with significant improvement in symptoms in patients with IBS-D and was well-tolerated. These results suggest that probiotics confer a benefit in IBS-D patients which deserves further investigation. TRIAL REGISTRATION: [Clinicaltrials.gov NCT03251625 ; retrospectively registered on August 9, 2017].

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12876-018-0788-9

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study protocol
Fig. 1 Study protocolCC BY · PubMed Central
Fig. 2 IBS-SSS abdominal pain ratings with probiotic (Bio-Kult®) or placebo (16 weeks’ treatment and 1-month follow-up). The lower the score the less the pain: * p = 0.002; ** p < 0.001; NS = not significant
Fig. 2 IBS-SSS abdominal pain ratings with probiotic (Bio-Kult®) or placebo (16 weeks’ treatment and 1-month follow-up). The lower the score the less the pain: * p = 0.002; ** p < 0.001; NS = not significantCC BY · PubMed Central
Fig. 3 Individual dimension scores for IBS-QoL during 16 weeks’ treatment with multi-strain probiotic (Bio-Kult®; blue square) or placebo (red square). * p < 0.05; ** p < 0.001; NS, not significant. Note: In this scoring system, higher scores indicate better QoL
Fig. 3 Individual dimension scores for IBS-QoL during 16 weeks’ treatment with multi-strain probiotic (Bio-Kult®; blue square) or placebo (red square). * p < 0.05; ** p < 0.001; NS, not significant. Note: In this scoring system, higher scores indicate better QoLCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 1

  1. Drossman DA, Richter JE, Talley NJ. The functional gastrointestinal bowel disorders, pathophysiology and treatment: a multinational consensus. Boston: Little Brown; 1994.

Cited by

See all 109

Metadata

Authors
Ishaque, S. M., Khosruzzaman, S. M., Ahmed, D. S., & Sah, M. P.
Affiliations
Bangladesh Medical University (BD)
Corresponding author
Ishaque, Shamsuddin M.
Venue
BMC Gastroenterology
Published
2018-05-25
Volume
18
Issue
1
Pages
71-71
ISSN
1471-230X (ISSN-L)
OpenAlex
W2807175397
Cited by
109
References
44
Citations by year
2026: 11 · 2025: 10 · 2024: 19 · 2023: 22 · 2022: 7 · 2021: 16 · 2020: 16 · 2019: 7 · 2018: 1
FWCI
9.53
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0/ (tdm)
Locations
  • BMC Gastroenterology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, multi-strain probiotics, diarrhea-predominant irritable bowel syndrome, abdominal pain, stool frequency, quality of life, gut microbiota, IBS symptom severity
MeSH terms
Gastrointestinal Microbiome, Adolescent, Adult, Diarrhea, Double-Blind Method, Female, Humans, Male, Middle Aged, Quality of Life, Severity of Illness Index, Abdominal Pain, Probiotics, Irritable Bowel Syndrome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome. https://app.cochat.ai/papers/10.1186/s12876-018-0788-9
The paper
Ishaque, S. M., Khosruzzaman, S. M., Ahmed, D. S., & Sah, M. P. (2018). A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome. BMC Gastroenterology. https://doi.org/10.1186/s12876-018-0788-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.